Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off
Agilent Navigates Market Challenges: Q3 Exceeds Expectations As Strategic Investments Pay Off
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.Agilent Technologies, Inc. (NYSE:A) shares are trading higher after the company reported third-quarter results yesterday.
Agilent Technologies, Inc. (紐交所:A)股票交易走高，該公司昨天發佈了第三季度業績報告。
Revenue fell 5.6% Y/Y to $1.58 billion, beating the consensus of $1.56 billion. By segment, the Life Sciences and Applied Markets Group (LSAG) segment reported revenue of $782 million, down 8% Y/Y (-7% Y/Y core), with an operating margin of 28.4%.
營業收入同比下降5.6%至15.8億美元，超過了市場預期的15.6億美元。按業務領域劃分，生命科學與應用市場集團（LSAG）的營業收入爲7.82億美元，同比下降8%（核心同比下降7%），營業利潤率爲28.4%。
The Agilent CrossLab Group (ACG) revenue came in at $411 million, up 4% Y/Y (+5% Y/Y core), with an operating margin of 34.0%.
Agilent CrossLab集團（ACG）的營業收入爲4.11億美元，同比增長4%（核心同比增長5%），營業利潤率爲34.0%。
The Diagnostics and Genomics Group (DGG) revenue stood at $385 million, down 9% Y/Y (-8% Y/Y core), with an operating margin of 18.3%.
診斷與基因組學集團（DGG）的營業收入爲3.85億美元，同比下降9%（核心同比下降8%），營業利潤率爲18.3%。
As of July 31, cash and cash equivalents stood at $1.78 billion. Adjusted EPS of $1.32 surpassed the street view of $1.26.
截至7月31日，現金及現金等價物爲17.8億美元。調整後的每股收益爲1.32美元，超過了市場預期的1.26美元。
Outlook: Agilent forecasts fourth-quarter revenue of $1.641 billion – $1.691 billion (vs. $1.67 billion estimate) and adjusted EPS of $1.38 – $1.42 (vs. street view of $1.44).
展望：Agilent預測第四季度的營業收入爲16.41億美元至16.91億美元（市場預期爲16.7億美元），調整後的每股收益爲1.38美元至1.42美元（市場預期爲1.44美元）。
For FY24, Agilent revised its revenue outlook to $6.45 billion – $6.5 billion from $6.42 billion – $6.5 billion (vs. $6.46 billion estimate) and adjusted EPS to $5.21 – $5.25 (vs. $5.20 estimate) from $5.15 – $5.25 earlier.
對於2024財年，Agilent將其營業收入展望修正爲6.45億美元至6.5億美元（市場預期爲6.42億美元至6.5億美元），調整後的每股收益爲5.21美元至5.25美元（市場預期爲5.20美元），之前爲5.15美元至5.25美元。
Agilent President and CEO Padraig McDonnell said, "While market conditions continued to be challenged during the quarter, we saw steady signs of improvement as anticipated. We continue to make investments in our most promising growth opportunities."
Agilent總裁兼首席執行官帕德里格·麥克唐納表示：「儘管本季度市場環境依然具有挑戰性，但我們看到了預期中的穩定好轉跡象。我們將繼續在最有前景的增長機會上進行投資。」
"And we are mobilizing the organization to accelerate value creation through strategic transformation initiatives, which will drive margin expansion and growth—and increase our execution capabilities."
我們正在調動組織力量，通過戰略轉型舉措加速價值創造，這將推動利潤擴張和增長，並提高我們的執行能力。
Investors can gain exposure to the stock via ProShares Nanotechnology ETF (NYSE:TINY) and VanEck ETF Trust VanEck Morningstar Wide Moat Growth ETF (BATS:MGRO).
投資者可以通過ProShares納米科技ETF（NYSE：TINY）和VanEck ETF Trust VanEck晨星寬基成長ETF（BATS：MGRO）獲得該股的曝光機會。
Price Action: A shares are up 1.88% at $142.63 at the last check Thursday.
價格波動：週四最新查看時，A股上漲1.88%，至142.63美元。
Image from Shutterstock
來自Shutterstock的圖片
- EHang Q2 Revenue Skyrockets 920% with Record eVTOL Deliveries: Details
- 億航Q2營業收入飆升920%，創紀錄的eVTOL交付詳細信息。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。
